Capsigen
Vancouver, US · 1 known investors
Capsigen engineers customized AAV (adeno-associated virus) capsids using its proprietary Transcription-Dependent Directed Evolution (TRADE) screening platform and data science to deliver gene therapies to specific target cells. The company develops fit-for-purpose viral vectors for treating difficult-to-treat diseases, including CNS and neuromuscular disorders.
Founders & leadership
Investors · 1
Competitors · 2
by search overlap
Biogen Idec4 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
Bioworld3 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Capsigen for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Capsigen do?
- Capsigen engineers customized AAV (adeno-associated virus) capsids using its proprietary Transcription-Dependent Directed Evolution (TRADE) screening platform and data science to deliver gene therapies to specific target cells. The company develops fit-for-purpose viral vectors for treating difficult-to-treat diseases, including CNS and neuromuscular disorders.
- Who are Capsigen's investors?
- Capsigen's investors include MC Healthcare Ventures.
- Where is Capsigen headquartered?
- Capsigen is headquartered in Vancouver, US.